logo

For the Inventor, By the Inventor

Indianapolis, IN, United States of America

K Jeff Thrasher

This inventor holds 8 USPTO granted patents. Top assignee: Eli Lilly and Company. Active years: 1991-1997.

IDiyas Innovation Intelligence. (2026). Inventor Profile: K Jeff Thrasher. Retrieved from https://idiyas.com/inventor/k-jeff-thrasher

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 8

% Patents Active = 100.0

Average Co-Inventor Count = 6.7

ph-index = 5

Forward Citations = 121(Granted Patents)


Location History:

  • Beech Grove, IN (US) (1991 - 1993)
  • Indianapolis, IN (US) (1995 - 1997)

Company Filing History:

goldMedal8 out of 4,522 
 
Eli Lilly and Company
 patents

Years Active: 1991-1997

Loading Chart...
8 patents (USPTO):Explore Patents
1. 5693633 - Angiotensin II antagonists (1997-12-02),
2. 5612360 - Angiotensin II antagonists (1997-03-18),
3. 5569768 - Angiotensin II antagonists (1996-10-29),
4. 5556981 - Angiotensin II antagonist intermediates (1996-09-17),
5. 5484780 - Angiotensin II antagonists (1996-01-16),
6. 5401851 - Angiotensin II antagonists (1995-03-28),
7. 5196427 - 3-aryl-4(3H) quinazolinone CCK antagonists and pharmaceutical (1993-03-23),
8. 5075313 - 3-aryl-4(3H)quinazolinone CCK antagonists and pharmaceutical (1991-12-24),

Title: **The Innovative Mind of K Jeff Thrasher: A Focus on Angiotensin II Antagonists**

Introduction

K Jeff Thrasher is a distinguished inventor based in Indianapolis, IN, known for his significant contributions to pharmaceutical innovations. With an impressive portfolio of eight patents, he has established himself as a prominent figure in the field of medical research and drug development.

Latest Patents

Among his recent works, K Jeff Thrasher has developed novel heterocyclic derivatives aimed at antagonizing angiotensin II receptors in mammals. This invention provides comprehensive pharmaceutical formulations that have the potential to enhance treatment options for conditions influenced by the angiotensin II pathway. The advancements presented in his patents are poised to drive innovations in therapies for cardiovascular and renal diseases.

Career Highlights

K Jeff Thrasher’s professional journey is closely tied to Eli Lilly and Company, where he has leveraged his expertise in drug design and development. His role at one of the leading pharmaceutical companies has allowed him to translate complex scientific ideas into tangible healthcare solutions. His dedication and innovative spirit have played a crucial role in advancing the company’s research and development efforts.

Collaborations

Throughout his career, Thrasher has collaborated with notable colleagues, including Donald B Boyd and Sherryl L Lifer. These partnerships have been instrumental in fostering a creative environment that encourages the exchange of ideas and the pursuit of groundbreaking discoveries in the pharmaceutical landscape.

Conclusion

K Jeff Thrasher exemplifies the spirit of innovation and dedication to improving healthcare through impactful inventions. With a focus on angiotensin II antagonists, his work continues to pave the way for advancements in medical treatments. As he further explores the boundaries of pharmaceutical sciences, the contributions of K Jeff Thrasher are sure to resonate in the field for years to come.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…